Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Pelcitoclax
Uterine Corpus Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Uterine Corpus Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Childhood Ependymoma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Diffuse Intrinsic Pontine Glioma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Medulloblastoma
National Cancer Institute (NCI)
P1
CC
(43)
Pembrolizumab
Ependymoma
National Cancer Institute (NCI)
P1
CC
(43)
Pidnarulex
Breast Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pidnarulex
Invasive Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pidnarulex
Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pidnarulex
HER2 Positive Breast Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pidnarulex
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pomalidomide
B-Cell Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Pomalidomide
Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Pomalidomide
Kaposi'S Sarcoma
National Cancer Institute (NCI)
P1
CC
(43)
Pomalidomide
Virus Associated Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Prednisone
Human T-Lymphotropic Virus 1 Infectious Disease
National Cancer Institute (NCI)
P1
CC
(43)
Prednisone
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Revumenib
Acute Myeloid Leukemia With Mutated NPM1
National Cancer Institute (NCI)
P1
CC
(43)
Riluzole
Melanoma
National Cancer Institute (NCI)
P1
CC
(43)
Rituximab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Rocakinogene Sifuplasmid
Hepatitis
National Cancer Institute (NCI)
P1
CC
(43)
Rocakinogene Sifuplasmid
Hepatitis C Virus Infection
National Cancer Institute (NCI)
P1
CC
(43)
Romidepsin
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Romidepsin
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Sapanisertib
Adult Glioblastoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2926 to 2950 of 3,272 assets
Previous
Page 118 of 131
Next